7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
CAS: 193002-25-4
Molecular Formula: C15H18N2O5
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one - Names and Identifiers
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one - Physico-chemical Properties
| Molecular Formula | C15H18N2O5 |
| Molar Mass | 306.31 |
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one - Upstream Downstream Industry
| Downstream Products | 4-Chloro-6-methoxy-7-(3-piperidin-1-yl-propoxy)-quinazoline |
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one - Introduction
7-hydroxy-6-methoxy -3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one (7-hydroxy-6-methoxy -3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one) is an organic compound. Its main properties are as follows:
1. Appearance: White crystalline solid.
2. Molecular formula: C17H20N2O4.
3. Molecular weight: 324.35g/mol.
4. Melting point: About 180-182 degrees Celsius.
5. Solubility: Soluble in chloroform, alcohol and Ester solvents, difficult to dissolve in water.
The main use of this compound is as an intermediate in the medical field. Specifically, it can be used to synthesize various compounds with biological activity, such as anticancer drugs and antibacterial drugs.
As for the production method, the synthesis of 7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one is generally carried out by a chemical synthesis method. Specific synthetic routes and procedures may require a more detailed understanding.
With regard to safety information, due to the specific chemical structure and properties of the compounds, the use and handling of the compounds need to follow the relevant safety procedures. The toxicological and dangerous properties of the compounds require further study and evaluation. Appropriate personal protective measures must be taken during use or handling to avoid inhalation, ingestion or skin contact. It is recommended that the compound be used and handled under the guidance of an experienced chemical professional.
1. Appearance: White crystalline solid.
2. Molecular formula: C17H20N2O4.
3. Molecular weight: 324.35g/mol.
4. Melting point: About 180-182 degrees Celsius.
5. Solubility: Soluble in chloroform, alcohol and Ester solvents, difficult to dissolve in water.
The main use of this compound is as an intermediate in the medical field. Specifically, it can be used to synthesize various compounds with biological activity, such as anticancer drugs and antibacterial drugs.
As for the production method, the synthesis of 7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one is generally carried out by a chemical synthesis method. Specific synthetic routes and procedures may require a more detailed understanding.
With regard to safety information, due to the specific chemical structure and properties of the compounds, the use and handling of the compounds need to follow the relevant safety procedures. The toxicological and dangerous properties of the compounds require further study and evaluation. Appropriate personal protective measures must be taken during use or handling to avoid inhalation, ingestion or skin contact. It is recommended that the compound be used and handled under the guidance of an experienced chemical professional.
Last Update：2024-04-09 22:09:11
![7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one](http://res.chembk.com/assets/str/2d/1/19/193002-25-4.png)
Supplier List
View History
7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one
USP-地西泮相关化合物B
tert-Butyl 4-[(2-aminophenoxy)methyl]piperidine-1-carboxylate
MAGNESIUM PYROPHOSPHATE
依那普利杂质I
RAFFINOSE, 5-HYDRATE
Telotristat Dibesilate
5 - 氯-2 - 甲基吡唑并[1,5-A]嘧啶
7,7-二氟-6-甲基双环[4.1.0]庚烷-3-羧酸
1-deoxysphinganine (m18:0)
USP-地西泮相关化合物B
tert-Butyl 4-[(2-aminophenoxy)methyl]piperidine-1-carboxylate
MAGNESIUM PYROPHOSPHATE
依那普利杂质I
RAFFINOSE, 5-HYDRATE
Telotristat Dibesilate
5 - 氯-2 - 甲基吡唑并[1,5-A]嘧啶
7,7-二氟-6-甲基双环[4.1.0]庚烷-3-羧酸
1-deoxysphinganine (m18:0)
Downstream Products for 7-Hydroxy-6-methoxy-3-[(pivaloyloxy)methyl]-3,4-dihydroquinazolin-4-one